跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 26,726 条关于
“Eventide Asset Management”
全部
26,726
临床试验
17,204
药物
161
机构
228
资讯
9,133
去年
Belite Bio Raises $275 Million in Upsized Private Placement to Advance Retinal Disease Therapies
去年
Inventiva Secures €348 Million to Advance Lanifibranor Phase III Trial for MASH
4个月前
Quince Therapeutics Acquires Orphai for $187M to Advance Inhaled Rapamycin Pipeline for Rare Pulmonary Diseases
3个月前
Leo Cancer Care Raises $65M Series D Following World-First Upright Proton Therapy Treatment at Stanford Medicine
11个月前
Ovid Therapeutics Secures $175M PIPE Financing to Advance CNS Drug Pipeline Through 2028
2个月前
AdvanCell Raises Record $450 Million to Advance Lead-212 Alpha Therapy into Phase III for Prostate Cancer
去年
BBOT Completes $382 Million SPAC Merger to Advance Next-Generation RAS-Targeted Cancer Therapeutics
2个月前
Flare Therapeutics Secures $85M Series C, Appoints Anna Protopapas as CEO to Advance First-in-Class ARON Degrader for Prostate Cancer
去年
Acelyrin's Izokibep Advances in Phase 3 Trials Amidst Analyst Revisions and Institutional Investment
去年
Norstella Launches NorstellaLinQ, an Integrated Data Asset for Biopharma
第 1 页,共 914 页
上一页
下一页